anmelden
Novartis Aktie
127,94
EUR
-0,20
EUR
-0,16
%
118,30
CHF
±0,00
CHF
±0,00
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 03.09.14 | Novartis Halten | Independent Research GmbH | |
| 02.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 01.09.14 | Novartis buy | UBS AG | |
| 01.09.14 | Novartis Hold | Kepler Cheuvreux | |
| 01.09.14 | Novartis Hold | Deutsche Bank AG | |
| 26.08.14 | Novartis Hold | Kelper Cheuvreux | |
| 22.08.14 | Novartis Outperform | Credit Suisse Group | |
| 21.08.14 | Novartis buy | Société Générale Group S.A. (SG) | |
|
Werbung
|
|||
| 21.08.14 | Novartis Hold | Deutsche Bank AG | |
| 19.08.14 | Novartis buy | UBS AG | |
| 05.08.14 | Novartis Hold | Deutsche Bank AG | |
| 21.07.14 | Novartis Underweight | Morgan Stanley | |
| 21.07.14 | Novartis Equal weight | Barclays Capital | |
| 21.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 17.07.14 | Novartis buy | S&P Capital IQ | |
| 15.07.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.07.14 | Novartis buy | UBS AG | |
| 14.07.14 | Novartis buy | Jefferies & Company Inc. | |
| 14.07.14 | Novartis buy | Jefferies & Company Inc. | |
| 07.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 07.07.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 02.07.14 | Novartis Hold | Deutsche Bank AG | |
| 02.07.14 | Novartis buy | UBS AG | |
| 20.06.14 | Novartis Underweight | Morgan Stanley | |
| 19.06.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.06.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.06.14 | Novartis buy | UBS AG | |
| 18.06.14 | Novartis Outperform | Bernstein Research | |
| 09.06.14 | Novartis Equal weight | Barclays Capital | |
| 04.06.14 | Novartis Hold | Deutsche Bank AG | |
| 03.06.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 03.06.14 | Novartis Halten | Independent Research GmbH | |
| 02.06.14 | Novartis Underweight | Morgan Stanley | |
| 27.05.14 | Novartis Outperform | BNP PARIBAS | |
| 27.05.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 16.05.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 15.05.14 | Novartis Underweight | Morgan Stanley | |
| 15.05.14 | Novartis Hold | Deutsche Bank AG | |
| 13.05.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 12.05.14 | Novartis Hold | Deutsche Bank AG | |
| 07.05.14 | Novartis buy | UBS AG | |
| 02.05.14 | Novartis buy | Jefferies & Company Inc. | |
| 30.04.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 29.04.14 | Novartis Underweight | Morgan Stanley | |
| 29.04.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.04.14 | Novartis Hold | Deutsche Bank AG | |
| 24.04.14 | Novartis Halten | Independent Research GmbH | |
| 24.04.14 | Novartis buy | UBS AG | |
| 23.04.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 23.04.14 | Novartis buy | S&P Capital IQ | |
Werbung
Werbung